Innovating Works

EUROPEAN VACCINE INITIATIVE e.V

Showing 1 to 20 of 22 results
DRAIGON: Diagnosing Infections with Multi-Drug Resistant Microorganisms using AI-powered Genomic Antibiotic S... EUROPEAN VACCINE INITIATIVE E.V tramitó un HORIZON EUROPE HORIZON-HLTH-2023-TOOL-05 The silent pandemic of antimicrobial resistance (AMR) is a growing global health crisis with a projected annual mortality rate of 10 million...
2023-12-13 - 2027-12-31 | Financiado
CAPTIVATE: CorrelAtes of Protective immuniTy-driven Investigation of malaria VAccine combinaTion stratEgies EUROPEAN VACCINE INITIATIVE E.V tramitó un HORIZON EUROPE HORIZON-HLTH-2022-DISEASE-06-two-stage Malaria remains a serious health concern worldwide, with P. falciparum considered one of the deadliest human parasites. Yet, the currently a...
2023-11-01 - 2028-04-30 | Financiado
NOSEVAC: INNOVATIVE NASAL VACCINES TO PREVENT PATHOGEN COLONIZATION AND INFECTION IN THE UPPER RESPIRATORY TR... EUROPEAN VACCINE INITIATIVE E.V tramitó un HORIZON EUROPE HORIZON-HLTH-2022-DISEASE-06-two-stage Bacterial and viral respiratory infections are a leading cause of morbidity and mortality worldwide. Streptococcus pneumoniae and Bordetella...
2023-05-01 - 2028-04-30 | Financiado
UltiMalVax: A Vaccine Targeting Eradication of Malaria EUROPEAN VACCINE INITIATIVE E.V tramitó un HORIZON EUROPE HORIZON-HLTH-2022-DISEASE-06-two-stage Malaria killed about 640 thousand people in 2020, largely young children in Africa. Rapid recent progress has led to two anti-sporozoite vac...
2023-04-21 - 2027-04-30 | Financiado
ADVANCE-VAC4PM: Advancing The Clinical Development Of Placental Malaria Vaccines In The Context Of Capacity Building... EUROPEAN VACCINE INITIATIVE E.V tramitó un HORIZON EUROPE HORIZON-HLTH-2021-DISEASE-04 Placental malaria (PM) is a severe disease that affects a particularly vulnerable demographic group, pregnant women. The burden of disease i...
2022-05-20 - 2027-05-31 | Financiado
ISIDORe: Integrated Services for Infectious Disease Outbreak Research EUROPEAN VACCINE INITIATIVE E.V participó en un HORIZON EUROPE HORIZON-INFRA-2021-EMERGENCY-02 The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, proposes to assemble the largest...
2022-02-09 - 2025-07-31 | Financiado
PrIMAVeRa: Predicting the Impact of Monoclonal Antibodies Vaccines on Antimicrobial Resistance EUROPEAN VACCINE INITIATIVE E.V tramitó un H2020 H2020-JTI-IMI2-2020-23-two-stage Antibiotic resistance (AMR), a major threat to human health, is increasing in all bacteria through antibiotic-induced selection, cross-speci...
2021-11-09 - 2026-10-31 | Financiado
Inno4Vac: Innovations to accelerate vaccine development and manufacture EUROPEAN VACCINE INITIATIVE E.V tramitó un H2020 H2020-JTI-IMI2-2020-20-two-stage Inno4Vac proposes an ambitious programme that will harness the latest advances in immunology, disease modelling, and modelling for tackling...
2021-07-19 - 2027-02-28 | Financiado
VACCELERATE: VACCELERATE European Corona Vaccine Trial Accelerator Platform EUROPEAN VACCINE INITIATIVE E.V participó en un H2020 The ongoing COVID-19 pandemic creates an unprecedented burden worldwide. Vaccine-induced immunity is the only promising solution. There is c...
2021-02-17 - 2024-01-27 | Financiado
TRANSVAC-DS: DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE EUROPEAN VACCINE INITIATIVE E.V tramitó un H2020 H2020-SC5-2018-2019-2020 The TRANSVAC-DS project further builds on the outstanding success of EC-funded projects:TRANSVAC1 and TRANSVAC2 and proposes the establishme...
2020-06-09 - 2023-02-28 | Financiado
SHIGETECVAX: Early clinical development of a live attenuated combination vaccine against Shigella and ETEC diarr... EUROPEAN VACCINE INITIATIVE E.V tramitó un H2020 H2020-SC1-BHC-2018-2020 Although vaccination is an effective way to reduce the huge disease burden associated with diarrhoea caused by enteric pathogens, many attem...
2019-04-30 - 2025-02-28 | Financiado
TRANSVAC2: European Vaccine Research and Development Infrastructure EUROPEAN VACCINE INITIATIVE E.V tramitó un H2020 H2020-INFRAIA-2016-2017 TRANSVAC2 is the follow-up project to its successful predecessor project TRANSVAC, the European Network of Vaccine Research and Development...
2017-07-28 - 2023-04-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.